Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Feb 9;90(3):672-7.
doi: 10.1038/sj.bjc.6601601.

Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype

Affiliations

Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype

K Kawaguchi et al. Br J Cancer. .

Abstract

The fragile histidine triad (FHIT) gene, encompassing the FRA3B fragile site at chromosome 3p14.2, is a candidate tumour suppressor gene involved in a variety of tumours, including gastric carcinomas. Recently, it has been reported that the FHIT gene may be a target of damage in some of mismatch-deficient tumours. To clarify further the role of the Fhit protein in gastric carcinogenesis, we investigated whether Fhit expression in early gastric neoplasia is associated with mismatch repair protein expression and cellular phenotype. Fhit, Mlh1 and phenotypic expression were evaluated immunohistochemically in 87 early gastric neoplasias, comprising 32 adenomas and 55 intramucosal carcinomas, resected by endoscopic mucosal resection therapy. Significant loss or reduction of Fhit expression was noted in four (12.5%) of the 32 adenomas and 21 (38.2%) of the 55 intramucosal carcinomas. The rate of abnormal Fhit expression was significantly higher in intramucosal carcinomas than in adenomas (P=0.021). Moreover, reduced Fhit expression was found to be significantly associated with loss of Mlh1 expression in early gastric neoplasia (P=0.0011). Furthermore, we also detected a significant association between reduced Fhit expression and gastric phenotype (P=0.0018). These results suggested that reduced Fhit expression occurs in the early stage of gastric carcinogenesis and could be correlated with a lack of Mlh1 expression and gastric phenotype.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Fhit immunostaining in human gastric non-neoplastic and neoplastic tissues. (A) Negative immunostaining of an intramucosal carcinoma and positive immunostaining of a non-neoplastic epithelium. (B) Positive immunostaining of an adenomatous and non-neoplastic epithelium.
Figure 2
Figure 2
Mlh1 immunostaining in human gastric non-neoplastic and neoplastic tissues. (A) Negative immunostaining of an intramucosal carcinoma and positive immunostaining of a non-neoplastic epithelium. (B) Positive immunostaining of an intramucosal carcinoma and non-neoplastic epithelium.

References

    1. Andachi H, Yashima K, Koda M, Kawaguchi K, Kitamura A, Hosoda A, Kishimoto Y, Shiota G, Ito H, Makino M, Kaibara N, Kawasaki H, Murawaki Y (2002) Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma. Br J Cancer 87: 441–445 - PMC - PubMed
    1. Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM, Huebner K (1998) Loss of FHIT expression in gastric carcinoma. Cancer Res 58: 4708–4714 - PubMed
    1. Beak MJ, Kang H, Kim SE, Park JH, Lee SJ, Paik YK, Kim H (2001) Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. Br J Cancer 85: 1147–1152 - PMC - PubMed
    1. Capuzzi D, Santoro E, Hauck WW, Kovatich AJ, Rosato FE, Baffa R, Huebner K, McCue PA (2000) Fhit expression in gastric adenocarcinoma. Cancer 88: 24–34 - PubMed
    1. Caselli M, Marchisio M, Gaudio M, Saragoni L, Lanza G, Alvisi V, Bertagnolo V, Concu M, Capitani S, Caramelli E (2001) Fhit protein expression in human gastric cancer and related precancerous lesions. Oncol Rep 8: 1233–1237 - PubMed

MeSH terms